Skip to main content

Accomplishments

2025

With the help of Solutions Engineering, Product Managers, Data Scientists, and more:

  • Clear Rates

    • Prototyped a lab version of Clear Rates Data
    • Prototyped a lab version of UX to surface Clear Rates Data
    • From lab to v2.X, executed roadmap to get Clear Rates Data to production. Now powers Analyze Beta.
  • Market Solutions

    • Integrated Clear Rates into DPR at the top of the pipeline
    • Created custom accuracy logic in Clear Rates for Drugs
    • Integrated Clear Rates into Network Check at the top of the pipeline
    • In progress:
      • Build Network Check-specific imputation tiers into Clear Rates
      • Replacing Network Check pipeline with Clear Rates Dataset
  • Consumer

    • Core Consumer Pricing Service is powered entirely by Clear Rates
    • Integrated NYC-DOH custom plans into Clear Rates
    • Built pipeline to power Eli Lilly Consumer Product, surfacing Medicare and Medicare Advantage prices for Kisunla-centered
  • Spines

    • Prototyped and built Physician Groups Spines
      • This work made both Consumer and Employer Clear Rates integration possible
    • Prototyped and built Physicians Spines
    • Prototyped and built Infusion Center Spines
      • further expands Clear Rates coverage for Life Sciences
      • removes Life Sciences dependencies on Provider Demographics / Provider Profiles
      • allows Consumer to use Infusion Centers
    • Prototyped and build Laboratories Spines
      • formalizes Clear Rates' inclusion of laboratories
      • removes Life Sciences dependencies on Provider Demographics / Provider Profiles
    • Created a DAG to generate Legacy Provider Demographics (pre-cursor to Spines across most data products)
    • Created a DAG to generate Legacy Provider Profiles (pre-cursor to Spines in Life Sciences)
  • Reference Data

    • Temporarily re-built Medicare Pricing pipeline from scratch to hit Medicare Pricing API to solve a Medicare reference data issue.
      • Demonstrates this team's ability to step in and solve critical issues outside of our direct ownership.
On this page: